Vertex Pharmaceuticals Incorporated Hepatitis C Drug Meets Study Goal
CAMBRIDGE, Mass. - Vertex Pharmaceuticals Inc. said late Thursday its hepatitis C drug candidate telaprevir was both safe and prompted a response in patients during a midstage study.